Cargando…

Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer

Cancer stem cells (CSCs), initially identified in leukemia in 1994, constitute a distinct subset of tumor cells characterized by surface markers such as CD133, CD44, and ALDH. Their behavior is regulated through a complex interplay of networks, including transcriptional, post-transcriptional, epigen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Zhen, Fu, Minyang, Hu, Yuan, Wei, Yuquan, Wei, Xiawei, Luo, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583419/ https://www.ncbi.nlm.nih.gov/pubmed/37853437 http://dx.doi.org/10.1186/s12943-023-01877-w

Ejemplares similares

Targeting TGF-β signal transduction for fibrosis and cancer therapy
por: Peng, Dandan, et al.
Publicado: (2022)

Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases
por: Fu, Minyang, et al.
Publicado: (2022)

Cancer vaccines as promising immuno-therapeutics: platforms and current progress
por: Liu, Jian, et al.
Publicado: (2022)

The Hippo signalling pathway and its implications in human health and diseases
por: Fu, Minyang, et al.
Publicado: (2022)

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
por: Xu, Maosen, et al.
Publicado: (2021)

cGAS-STING pathway in cancer biotherapy
por: Wang, Yang, et al.
Publicado: (2020)

Targeting the tumor stroma for cancer therapy
por: Xu, Maosen, et al.
Publicado: (2022)

Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
por: Liu, Guihong, et al.
Publicado: (2021)

Mesenchymal stem/stromal cells in cancer therapy
por: Lan, Tianxia, et al.
Publicado: (2021)

Targeting PI3K in cancer: mechanisms and advances in clinical trials
por: Yang, Jing, et al.
Publicado: (2019)

CCL5/CCR5 axis in human diseases and related treatments
por: Zeng, Zhen, et al.
Publicado: (2021)

Mitochondrial DNA in the regulation of innate immune responses
por: Fang, Chunju, et al.
Publicado: (2015)

Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin
por: Cheng, Yuan, et al.
Publicado: (2021)

JMJD3 in the regulation of human diseases
por: Zhang, Xiangxian, et al.
Publicado: (2019)

Signaling pathways in the regulation of cancer stem cells and associated targeted therapy
por: Manni, Wang, et al.
Publicado: (2022)

AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
por: Zhu, Chenjing, et al.
Publicado: (2019)

Molecular mechanisms and clinical management of cancer bone metastasis
por: Wang, Manni, et al.
Publicado: (2020)

Ammonia promotes the proliferation of bone marrow-derived mesenchymal stem cells by regulating the Akt/mTOR/S6k pathway
por: Liu, Yu, et al.
Publicado: (2022)

The role of lysosome in regulated necrosis
por: Alu, Aqu, et al.
Publicado: (2020)

DNA-PK inhibition by M3814 enhances chemosensitivity in non-small cell lung cancer
por: Wang, Manni, et al.
Publicado: (2021)

Epigenetic regulation of macrophages: from homeostasis maintenance to host defense
por: Chen, Siyuan, et al.
Publicado: (2019)

The modulatory effect of high salt on immune cells and related diseases
por: Li, Xian, et al.
Publicado: (2022)

Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease
por: Wei, Xiawei, et al.
Publicado: (2019)

JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis
por: Chen, Siyuan, et al.
Publicado: (2023)

Protocols for measuring phosphorylation, subcellular localization, and kinase activity of Hippo pathway components YAP and LATS in cultured cells
por: Luo, Min, et al.
Publicado: (2022)

Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications
por: Wang, Lei, et al.
Publicado: (2022)

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
por: Cheng, Yuan, et al.
Publicado: (2019)

Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment
por: Koury, Jeffrey, et al.
Publicado: (2017)

Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection
por: Tang, Fan, et al.
Publicado: (2020)

Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness
por: Espinosa-Sánchez, Asunción, et al.
Publicado: (2020)

Cellular Toxicity and Immunological Effects of Carbon-based Nanomaterials
por: Yuan, Xia, et al.
Publicado: (2019)

Ikaros Proteins in Tumor: Current Perspectives and New Developments
por: Xia, Ruolan, et al.
Publicado: (2021)

Targeting the MDSCs of Tumors In Situ With Inhibitors of the MAPK Signaling Pathway to Promote Tumor Regression
por: Yu, Jiayun, et al.
Publicado: (2021)

Signaling pathways in rheumatoid arthritis: implications for targeted therapy
por: Ding, Qian, et al.
Publicado: (2023)

Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics
por: Borlongan, Mia C., et al.
Publicado: (2023)

Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy
por: Han, Xuejiao, et al.
Publicado: (2022)

Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
por: Borah, A, et al.
Publicado: (2015)

The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
por: Yuan, Jimin, et al.
Publicado: (2020)

Jumonji domain‐containing protein 6 protein and its role in cancer
por: Yang, Jing, et al.
Publicado: (2020)

Emerging agents that target signaling pathways in cancer stem cells
por: Yang, Yue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9j0algnpommphr7jthsvr8cpam